Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-CLOSE trial
KCT0003911Phase 4Completed
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Samjin Pharmaceutical Co., Ltd. Started Aug 2019; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on KCT0003911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003911.